• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

BaroNova

BaroNova wins FDA nod for TransPyloric Shuttle weight loss device

April 23, 2019 By Fink Densford

BaroNova said today that it won FDA approval for its TransPyloric Shuttle non-surgical device intended for treating obesity, now cleared as a weight loss solution for adults with obesity and a body mass index of 30 to 40 kg/m2. The San Carlos, Calif.-based company said that the device is approved for up to 12 months […]

Filed Under: Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Weight loss Tagged With: BaroNova

BaroNova touts TransPyloric Shuttle pivotal study data

November 19, 2018 By Fink Densford

BaroNova late last week released the primary results from the pivotal ENDObesityII study of its TransPyloric Shuttle device intended to treat obesity. Results from the trial were presented at the Obesity Week 2018 conference’s scientific sessions, the San Carlos, Calif.-based company said. “Obesity is a worldwide epidemic with up to 40% of adult Americans suffering from […]

Filed Under: Clinical Trials, Weight loss Tagged With: BaroNova

Wright Medical COO, ex-Tornier CEO Mowry, steps down | Personnel Moves May 5, 2016

May 5, 2016 By Fink Densford

Wright Medical COO, ex-Tornier CEO Mowry, steps down Wright Medical (NSDQ:WMGI) said yesterday its exec veep and chief operating officer, and former Tornier (NSDQ:TRNX) CEO, David Mowry will be stepping down from the company on May 6 to pursue other opportunities. The company did not indicate who would take Mowry’s position. Read more

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11

Filed Under: Business/Financial News Tagged With: Alfred Mann Foundation, Asante Solutions, BaroNova, Baxter, Biolase, Capsule Tech Inc., Gynesonics, Medtronic, NeoChord Inc., Neurotech Pharmaceuticals, NinePoint Medical Inc., Notal Vision, Olympus, Patient Safety Technologies Inc., Repro Med Systems, SafeOp Surgical, Tornier Inc., wrightmedical

The steady and successful climb of BaroNova

February 18, 2016 By Scott Nelson

Welcome to the Medsiderplu interview, a special new feature at MassDevice, which will appear regularly. All interviews are conducted by Scott Nelson, Founder, Medsider. We hope you enjoy them. Henry Ford is famous for stating, “If I had asked people what they wanted, I would have built a faster horse.” Although it’s arguable whether he […]

Filed Under: Blog Tagged With: BaroNova, medsider

BaroNova launches TPS weight-loss trial

December 11, 2015 By Fink Densford

BaroNova said today it enrolled the 1st 4 patients in its ENDObesity II study pivotal clinical trial to test its TransPyloric Shuttle designed to treat obesity. The TransPyloric Shuttle is inserted and removed through the mouth endoscopically to slow gastric emptying and encourage weight loss, the company said. In a feasibility study, patients with BMIs […]

Filed Under: Clinical Trials, Weight loss Tagged With: BaroNova

Weight Loss: BaroNova nets $36.5m in Series D

November 23, 2015 By Fink Densford

Weight loss company BaroNova said it closed a $36.5 million Series D round of financing for its TransPyloric Shuttle endoscopically delivered and retrievable weight-loss device. The round was led by Delos Capital and Longitude Capital, and joined by existing investors Lumira Capital Partners, Onset ventures and Sante Ventures. “We are very excited about the opportunity to […]

Filed Under: Business/Financial News, Weight loss Tagged With: BaroNova

Weight loss: Boston Scientific backs BaroNova in $27M funding round

February 15, 2013 By MassDevice staff Leave a Comment

BaroNova
Boston Scientific

Boston Scientific (NYSE:BSX) took part in a $27.3 million Series C round for weight loss device maker BaroNova, joined by Sante Ventures, Lumira Capital and a bevy of other venture capital shops.

Filed Under: Funding Roundup, News Well, Weight loss Tagged With: Bariatrics, BaroNova, Boston Scientific, Venture Capital/Private Equity

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS